Use for cannabinoid

Roger Guy Pertwee; Geoffrey W Guy

Use for cannabinoid

Roger Guy Pertwee (Inventor)
, Geoffrey W Guy (Inventor)

Medical Sciences

GW Pharma

Research output: Patent

Abstract

The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.

Original language	English
Patent number	US2008119544
IPC	A61K31/353; A61K36/185; A61K31/352;
Publication status	Published - 22 May 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@misc{870f2dfe95114ab9859ccba42518838d,

title = "Use for cannabinoid",

abstract = "The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency. ",

author = "Pertwee, \{Roger Guy\} and Guy, \{Geoffrey W\}",

year = "2008",

month = may,

day = "22",

language = "English",

type = "Patent",

note = "US2008119544; A61K31/353; A61K36/185; A61K31/352; ",

}

TY - PAT

T1 - Use for cannabinoid

AU - Pertwee, Roger Guy

AU - Guy, Geoffrey W

PY - 2008/5/22

Y1 - 2008/5/22

N2 - The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.

AB - The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.

M3 - Patent

M1 - US2008119544

ER -

Use for cannabinoid

Abstract

UN SDGs

Fingerprint

Cite this